Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms
暂无分享,去创建一个
W. R. Burack | L. Medeiros | J. Liesveld | N. Pemmaraju | S. Loghavi | Wei Wang | M. Yabe | Hong Fang | F. Jelloul | A. Evans | John M. Bennett | S. El Hussein | Wei Wang | W. Burack
[1] L. Medeiros,et al. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon , 2021, Leukemia & lymphoma.
[2] N. Pemmaraju. Targeting the p-D-C: easy as C-D-1-2-3? , 2021, Blood.
[3] F. Jardin,et al. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape , 2020, Haematologica.
[4] B. Thakral,et al. CD123+CD4+CD56+ neoplasm: blastic plasmacytoid dendritic cell neoplasm or acute myeloid leukemia? , 2020, Blood.
[5] M. Arcila,et al. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1 mutated acute myeloid leukemia. , 2020, Blood.
[6] L. Medeiros,et al. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a ten-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm , 2020, Haematologica.
[7] M. Gobbi,et al. Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients , 2020, Leukemia & lymphoma.
[8] H. Meyerson,et al. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation , 2020, Cytometry. Part B, Clinical cytometry.
[9] Yan-rong Liu,et al. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells , 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[10] Hannah C. Beird,et al. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era , 2019, Blood.
[11] E. Solary,et al. Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia , 2019, Leukemia.
[12] M. Gobbi,et al. A blastic plasmacytoid dendritic cell neoplasm‐like phenotype identifies a subgroup of npm1‐mutated acute myeloid leukemia patients with worse prognosis , 2018, American journal of hematology.
[13] S. Swerdlow. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues , 2017 .
[14] W. Vermi,et al. Neoplasms derived from plasmacytoid dendritic cells , 2016, Modern Pathology.
[15] T. Petrella,et al. Specific Skin Lesions in Chronic Myelomonocytic Leukemia: A Spectrum of Myelomonocytic and Dendritic Cell Proliferations. A Study of 42 Cases , 2012, The American journal of surgical pathology.